Lipocine Historical Income Statement

LPCN Stock  USD 5.15  0.15  3.00%   
Historical analysis of Lipocine income statement accounts such as Research Development of 9.1 M can show how well Lipocine performed in making a profits. Evaluating Lipocine income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Lipocine's future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Lipocine latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lipocine is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.

About Lipocine Income Statement Analysis

Lipocine Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Lipocine shareholders. The income statement also shows Lipocine investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Lipocine Income Statement Chart

At this time, Lipocine's Interest Income is very stable compared to the past year.

Operating Income

Operating Income is the amount of profit realized from Lipocine operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Lipocine is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Cost Of Revenue

Cost of Revenue is found on Lipocine income statement and represents the costs associated with goods and services Lipocine provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Lipocine financial statement analysis. It represents the amount of money remaining after all of Lipocine operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Lipocine's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Lipocine current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.At this time, Lipocine's Interest Income is very stable compared to the past year.
 2021 2022 2023 2024 (projected)
Total Operating Expenses16.6M11.8M15.1M9.3M
Cost Of Revenue7.7M8.6M10.2M9.4M

Lipocine income statement Correlations

-0.30.9-0.75-0.80.64-0.80.540.66-0.82-0.82-0.14-0.54-0.82-0.15-0.04-0.06-0.28-0.2-0.130.020.03
-0.3-0.260.780.69-0.370.69-0.370.020.70.70.130.770.7-0.610.010.36-0.26-0.41-0.14-0.34-0.4
0.9-0.26-0.78-0.850.88-0.850.80.72-0.85-0.85-0.14-0.56-0.85-0.15-0.03-0.11-0.34-0.29-0.270.120.11
-0.750.78-0.780.98-0.790.98-0.74-0.380.990.990.180.870.99-0.34-0.020.3-0.02-0.170.02-0.27-0.31
-0.80.69-0.850.98-0.851.0-0.81-0.440.990.990.080.850.99-0.280.010.260.06-0.080.05-0.23-0.26
0.64-0.370.88-0.79-0.85-0.850.980.48-0.82-0.82-0.02-0.65-0.820.130.04-0.15-0.11-0.08-0.20.190.19
-0.80.69-0.850.981.0-0.85-0.81-0.440.990.990.080.850.99-0.280.010.260.06-0.080.05-0.23-0.26
0.54-0.370.8-0.74-0.810.98-0.810.39-0.76-0.760.1-0.64-0.760.190.08-0.15-0.040.01-0.150.170.18
0.660.020.72-0.38-0.440.48-0.440.39-0.47-0.47-0.03-0.02-0.47-0.330.04-0.2-0.62-0.72-0.760.350.31
-0.820.7-0.850.990.99-0.820.99-0.76-0.471.00.190.861.0-0.190.00.230.08-0.060.05-0.19-0.23
-0.820.7-0.850.990.99-0.820.99-0.76-0.471.00.190.861.0-0.190.00.230.08-0.060.05-0.19-0.23
-0.140.13-0.140.180.08-0.020.080.1-0.030.190.190.190.190.29-0.02-0.04-0.05-0.06-0.060.050.05
-0.540.77-0.560.870.85-0.650.85-0.64-0.020.860.860.190.86-0.270.07-0.03-0.21-0.36-0.40.130.06
-0.820.7-0.850.990.99-0.820.99-0.76-0.471.01.00.190.86-0.190.00.230.08-0.060.05-0.19-0.22
-0.15-0.61-0.15-0.34-0.280.13-0.280.19-0.33-0.19-0.190.29-0.27-0.190.06-0.480.460.540.060.560.59
-0.040.01-0.03-0.020.010.040.010.080.040.00.0-0.020.070.00.06-0.160.560.29-0.150.170.17
-0.060.36-0.110.30.26-0.150.26-0.15-0.20.230.23-0.04-0.030.23-0.48-0.160.2-0.10.48-0.89-0.91
-0.28-0.26-0.34-0.020.06-0.110.06-0.04-0.620.080.08-0.05-0.210.080.460.560.20.790.53-0.15-0.13
-0.2-0.41-0.29-0.17-0.08-0.08-0.080.01-0.72-0.06-0.06-0.06-0.36-0.060.540.29-0.10.790.69-0.070.01
-0.13-0.14-0.270.020.05-0.20.05-0.15-0.760.050.05-0.06-0.40.050.06-0.150.480.530.69-0.7-0.63
0.02-0.340.12-0.27-0.230.19-0.230.170.35-0.19-0.190.050.13-0.190.560.17-0.89-0.15-0.07-0.70.99
0.03-0.40.11-0.31-0.260.19-0.260.180.31-0.23-0.230.050.06-0.220.590.17-0.91-0.130.01-0.630.99
Click cells to compare fundamentals

Lipocine Account Relationship Matchups

Pair Trading with Lipocine

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lipocine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will appreciate offsetting losses from the drop in the long position's value.

Moving against Lipocine Stock

  0.75GMAB Genmab ASPairCorr
  0.7VALN Valneva SE ADRPairCorr
  0.7LEGN Legend Biotech CorpPairCorr
  0.68VCNX VaccinexPairCorr
  0.67MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
The ability to find closely correlated positions to Lipocine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lipocine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lipocine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lipocine to buy it.
The correlation of Lipocine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lipocine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lipocine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lipocine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.75)
Revenue Per Share
0.903
Quarterly Revenue Growth
137.519
Return On Assets
(0.23)
Return On Equity
(0.34)
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.